Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of Petros Pharmaceuticals, Inc. and Subsidiaries (the “Company”) on Form S-1 to be filed on or about February 14, 2025 of our report dated March 31, 2023, on our audit of the consolidated financial statements as of December 31, 2022 and for the year then ended, which report is included in Amendment No. 3 to the Registration Statement on Form S-1 (333-284495) filed February 14, 2025. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company's ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in Amendment No. 3 to the Registration Statement on Form S-1 (333-284495) filed February 14 ,2025 incorporated by reference in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
February 14, 2025
